...
首页> 外文期刊>Trials >Right versus left atrial pacing in patients with sick sinus syndrome and paroxysmal atrial fibrillation (Riverleft study): study protocol for randomized controlled trial
【24h】

Right versus left atrial pacing in patients with sick sinus syndrome and paroxysmal atrial fibrillation (Riverleft study): study protocol for randomized controlled trial

机译:病态窦房结综合征和阵发性房颤患者的右房和左房起搏(Riverleft研究):随机对照试验的研究方案

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background The incidence of sick sinus syndrome will increase due to population ageing. Consequently, this will result in an increase in the number of pacemaker implantations. The atrial lead is usually implanted in the right atrial appendage, but this position may be ineffective for prevention of atrial fibrillation. It has been suggested that pacing distally in the coronary sinus might be more successful in preventing atrial fibrillation episodes. The aim of this trial is to study the efficacy of distal coronary sinus versus right atrial appendage pacing in preventing atrial fibrillation episodes in patients with sick sinus syndrome. Methods/Design This study is designed as a multicenter, randomized controlled trial. Patients with sick sinus syndrome and at least one atrial fibrillation episode of 30 seconds or more in the six months before recruitment will be eligible for participation in this study. All participants will be randomized between pacing distally in the coronary sinus and right atrial appendage. Randomization is stratified for all participating centers. Conventional dual-chamber pacemakers with advanced home monitoring functionality will be implanted. The ventricular lead will be implanted in the right ventricular apex. The first three months of the 36-month follow-up period are considered as run-in time. During the pre-randomization visit and follow-up, an interview, electrocardiogram and pacemaker assessment will be performed, prescribed antiarrhythmic medication will be reviewed and patients will be asked to complete an SF-36 questionnaire. An echocardiographic examination will be conducted in the pre-randomization phase and at the end of each follow-up year. Home monitoring will be used to send daily reports in case of atrial fibrillation episodes. Discussion This randomized controlled trial is the first in which home monitoring will be used to compare atrial fibrillation recurrences between pacing in the distal coronary sinus or right atrial appendage. Home monitoring gives the opportunity to accurately detect atrial fibrillation episodes and to study characteristics of atrial fibrillation episodes. Should distal coronary sinus pacing significantly diminish atrial fibrillation recurrences, this study will redefine the preferential location of an atrial lead for preventive pacing. Trial registration Current Controlled Trials ISRCTN65911661 , registered on 8 July 2013.
机译:背景技术由于人口老龄化,患病鼻窦综合症的发病率将增加。因此,这将导致起搏器植入的数量增加。通常将心房引线植入右心耳中,但该位置可能无法有效防止房颤。有人提出,在冠状窦的远端起搏可能更能预防房颤的发生。该试验的目的是研究远端冠状窦与右心耳起搏在预防病态窦房结综合征患者房颤中的作用。方法/设计本研究设计为多中心随机对照试验。患有病态窦房结综合征且在入选前六个月内至少发生一次心房纤颤发作且持续30秒或更长时间的患者将有资格参加本研究。所有参与者将被随机分配在冠状窦的远端起搏和右心耳之间。所有参与中心的随机分组。具有先进家庭监控功能的传统双室起搏器将被植入。心室导线将植入右心室先端。 36个月随访期的前三个月被认为是磨合期。在随机化访视和随访期间,将进行访谈,心电图和起搏器评估,将对处方的抗心律失常药物进行复查,并要求患者填写SF-36问卷。在随机化前阶段和每个随访年末将进行超声心动图检查。如果发生房颤,家庭监测将用于发送每日报告。讨论该随机对照试验是首次使用家庭监测来比较远端冠状静脉窦或右心耳的起搏之间的房颤复发情况。家庭监护使您有机会准确地检测房颤发作并研究房颤发作的特征。如果远端冠状窦起搏明显减少了心房纤颤的复发,这项研究将重新定义预防性起搏的心房导线的优先位置。试用注册当前对照试验ISRCTN65911661,于2013年7月8日注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号